Abiopharma

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

Empery Digital Rejects Invalid Nomination Notices from Dissident Stockholders

Norwegian Cruise Line Holdings Announces Board Refreshment

Net Asset Value(s)

Summit Plc - Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026

Ocean Power Technologies Secures Order for Fully Integrated WAM-V for an Underwater Research Customer in the Nordics

Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026

NFL Hall of Famer Troy Aikman Visits VENU’s Award-Winning Ford Amphitheater

Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status

Opera Files Its 2025 Annual Report on Form 20-F